To achieve the target BG and minimize the risk of hypoglycemia in the intensive protocol, it is necessary to improve current practice in surgical patients by ensuring the appropriate insulin delivery and management protocol according to the best available evidence. The gene discussed is INS; the disease is Hypoglycemia.